Clinical Trials Logo

Clinical Trial Summary

The objective of the RHAPSODY study is to evaluate the performance of new software features in subjects undergoing standard of care catheter-based endocardial mapping for atrial or ventricular tachyarrhythmias using a commercial Rhythmia Mapping System. Results from this study will be used to guide development and refinement of new software features that may be implemented in future commercial software releases.


Clinical Trial Description

The Rhythmia Mapping System is designed for electroanatomical mapping in catheter ablation procedures by optimizing the need for speed and accuracy. The system is able to simultaneously acquire data from multiple electrodes. In addition, based on user-defined criteria, the system is able to efficiently acquire data over multiple cardiac beats. When used in conjunction with the Rhythmia Mapping Catheter, the system is able to acquire up to hundreds of points per minute leading to fast and detailed map creation. Since its market release, physicians and users have gained experience with the Boston Scientific Rhythmia Mapping System in the human clinical setting. Improvements to the first generation system are in development and include new and improved software features and mapping algorithms to enhance the clinical operation. These new and improved software features and algorithms require leveraging clinical use data as part of the development and iteration process. This study will evaluate the performance of potential next-generation software features in a low-risk clinical environment by streaming raw signals from a commercial Rhythmia Workstation during standard of care cardiac mapping and ablation treatments for tachyarrhythmias, specifically atrial fibrillation, atrial tachycardias, and ventricular tachycardia. The data will be evaluated on a parallel investigational Rhythmia Workstation using prototype software features. These next-generation software features and algorithms will not be available to the physician during the case and will therefore have no diagnostic or therapeutic impact on the clinical case. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03053141
Study type Observational
Source Boston Scientific Corporation
Contact Sharda Mehta
Email sharda.mehta@bsci.com
Status Recruiting
Phase
Start date May 2016
Completion date March 2025

See also
  Status Clinical Trial Phase
Suspended NCT02741180 - Sparsity-based Magnetic Resonance Imaging of Cardiac Arrhythmias N/A
Not yet recruiting NCT03610529 - CardioSenseSystem Compared Study Regarding Efficacy and Safety in the Monitoring of ECG N/A
Completed NCT03662802 - Development of a Novel Convolution Neural Network for Arrhythmia Classification
Completed NCT03716076 - Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study Phase 4
Completed NCT03720639 - Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? A Randomized Clinical Study N/A
Recruiting NCT05968521 - Cardiac Rehabilitation for Young People N/A
Not yet recruiting NCT03450226 - Stellate Ganglion Block in Beating Heart Surgery N/A
Completed NCT04023461 - Isolation of Pulmonary Veins With PVAC GOLD in Elderly Patients Phase 4
Completed NCT03319160 - LifeVest Safety and Efficacy in Real Life Settings in France
Active, not recruiting NCT03444259 - Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients
Completed NCT03365440 - Esophageal 3D Mapping System for Cardiac Arrhythmias
Completed NCT03195647 - Pilot Study for the Tight K Study Phase 3
Completed NCT03607201 - Acute Coronary Syndrome in Diabetic Patients
Active, not recruiting NCT03614377 - DEvice-Detected CArdiac Tachyarrhythmic Events and Sleep-disordered Breathing (DEDiCATES)